Anti-human BCMA monoclonal antibody, belantamab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1171-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: 2857916, GSK2857916, J6M0, J6M0-mcMMAF
target BCMA
alias CD269, TNFRSF17, BCM, BCMA
gene id Uniprot ID: Q02223
host species Humanized
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human BCMA, mFc tagged protein binds to Anti-BCMA Neutralizing antibody in a linear range of 0.64-80.0 ng/ml

Flow cytometry analysis with Anti-BCMA mAb 1 ug/ml (belantamab) on K562 cells (Red histogram) or human BCMA positive K562 cells (Blue histogram).Human BCMA positive K562 cells were generated by human BCMA lentivirally transduced into K562 cell line and selected for monoclonal


PRODUCT

  • SKU

    DMS1171-100ug

  • Size

    100ug

  • Price

    $350

1